Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4+Foxp3+ T cells.

Translated title of the contribution: Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4+Foxp3+ T cells.

M.C. Minnema, M.S. van der Veer, M.I. Aarts-Riemens, M.E. Emmelot, T. Mutis, H.M. Lokhorst

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionLenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4+Foxp3+ T cells.
Original languageUndefined/Unknown
Pages (from-to)605-607
Number of pages3
JournalLeukemia
Volume23
Issue number3
Publication statusPublished - 2009

Cite this